The mechanism of iNOS overexpression in cancer is complex and involves activation of the NF-κB and STAT3 signaling pathways, which are often overactive in cancer cells and promote the expression of pro-inflammatory and proliferative genes. This evidence concerns the gene NOS2 and cancer.